The space cybersecurity market is expected to reach USD 6.96 billion by 2029, from USD 4.52 billion in 2024, at a CAGR of 9.0% according to a new report by MarketsandMarketstm. The market is driven by ...

Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of its manufacturing-grade IsoTagtm AAV reagent for the purification of Adeno-associated ...

BioAtla (BCAB) announced preclinical poster presentations at the upcoming 2025 American Association for Cancer Research to be held at the McCormick Place Convention Center in Chicago, IL from ...

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class ...

today announced a poster presentation at the upcoming 2025 American Society of Clinical Oncology (ASCO) Annual Meeting to be held online and at the McCormick Place Convention Center in Chicago ...

With a 71.7º tilt angle, the vertical design allows for a more natural hand position, which can help prevent discomfort that comes from using a flat mouse for extended periods. Plus, the extended ...

Additionally, two abstracts on another drug, AFM24, in combination with atezolizumab for treating non-small cell lung cancer (NSCLC) have been accepted for poster presentations. The oral ...

Two abstracts accepted for poster presentation highlight Company's proprietary Conditionally Active Biologic (CAB) technology Differentiated preclinical activity for CAB anti-Nectin4-antibody drug ...

Adagene Inc. announced a poster presentation for the ASCO 2025 conference ... computational biology and artificial intelligence to design novel antibodies that address globally unmet patient ...

This "trial-in-progress” presentation will focus on the design of the ongoing expansion portion of Mersana's Phase 1 clinical trial of Emi-Le that is actively enrolling patients with triple negative ...

Enliven's discovery process combines deep insights in clinically validated biological targets and differentiated chemistry to design potentially ... announces-poster-presentations-at-the-2025 ...

This “trial-in-progress” presentation will focus on the design of the ongoing expansion portion of Mersana’s Phase 1 clinical trial of Emi-Le that is actively enrolling patients with triple ...